{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-012761","form_type":"8-K","ticker":"CRVO","cik":"0001053691","company_name":"CervoMed Inc.","filed_at":"2024-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.063289+00:00","generated_at":"2026-06-03T11:14:11.602058+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"low","headline":"CervoMed reports 8,253,741 shares outstanding as of April 22, 2024","bullets":["Share count disclosed as 8,253,741 shares of common stock outstanding as of April 22, 2024.","No other material updates or events reported in the filing.","The corporate presentation made available on the company's website contains no new clinical or financial data disclosed in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-012761","json":"https://secwatch.observer/filing/0001437749-24-012761.json","markdown":"https://secwatch.observer/filing/0001437749-24-012761.md","text":"https://secwatch.observer/filing/0001437749-24-012761.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924012761/0001437749-24-012761-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924012761/crvo20240422_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T11:14:11.602058+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}